#USA #healthcare #PTC Therapeutics #Warren #Investor

PTC Therapeutics to Present at Notable Investor Conferences

PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced an exciting opportunity for investors and stakeholders as it prepares to participate in several prominent conferences in September 2026. The company's executives will share insights into their innovative research and developments in biopharmaceuticals at the following events:

1. Wells Fargo 21st Annual Healthcare Conference
- Date: Thursday, September 10, 2026
- Time: 9:30 a.m. ET

2. 2026 Cantor Global Healthcare Conference
- Date: Friday, September 11, 2026
- Time: 8:35 a.m. ET

3. Morgan Stanley 24th Annual Global Healthcare Conference
- Date: Tuesday, September 15, 2026
- Time: 9:15 a.m. ET

These presentations will not only provide valuable information to investors and analysts but will also highlight PTC Therapeutics' advancements and strategic outlook in the rapidly evolving healthcare landscape. All sessions will be available for live streaming via the Events and Presentations section of the PTC Therapeutics website at ptcbio.com and will remain accessible on-demand for 30 days after the live events.

About PTC Therapeutics

Established with a mission to revolutionize treatment for patients with rare genetic disorders, PTC Therapeutics is at the forefront of biopharmaceutical development. The company is renowned for its dedication to the discovery and commercialization of impactful medicines specifically designed for unique patient needs. By advancing a diverse pipeline, PTC aims to provide transformative treatment options that meet unmet medical needs, ensuring access to best-in-class therapies for both children and adults.

PTC's strategic approach leverages its extensive scientific expertise and global infrastructure to optimize healthcare solutions for patients worldwide. This endeavor not only enhances its reputation within the biopharmaceutical community but also solidifies its commitment to improving health outcomes for those affected by rare disorders.

In light of their upcoming participation in these investor conferences, PTC Therapeutics emphasizes its role as a leader in the industry and its resolve to foster engagement with the investment community. Stakeholders are encouraged to tune in and gain insights into the company’s future directions and innovations in biopharmaceuticals.

For further details, interested parties can reach out to PTC’s investor relations team or visit their website to explore the latest news and advancements from this dynamic company.

Contact Information

Investors:
Ellen Cavaleri
Phone: +1 (615) 618-8228
Email: [email protected]

Media:
Jeanine Clemente
Phone: +1 (908) 912-9406
Email: [email protected]

Stay connected with PTC Therapeutics on social media platforms such as LinkedIn, Twitter, Instagram, and Facebook for real-time updates and announcements.